Avraham H, Golenser J, Spira D T, Sulitzeanu D
Trans R Soc Trop Med Hyg. 1981;75(3):421-5. doi: 10.1016/0035-9203(81)90111-5.
Human red blood cells (RBC) infected in vitro with Plasmodium falciparum were employed to prepare several types of antigens (sonicated, infected RBC and purified, sonicated merozoites and schizonts). These antigens, as well as control preparations derived from non-infected RBC, were used to coat plastic tubes, which were subsequently tested for capacity to bind anti-P. falciparum antibodies. Binding was detected by means of radio-iodinated staphylococcus protein A. Sera from patients with recent disease or patients who had a history of P. falciparum infection gave strong binding, while sera of normal individuals had only a low binding activity. Some of the antibodies in the positive sera were directed against RBC, since they could bind to tubes coated with normal RBC antigens and could be removed by absorption with RBC. The specificity of the P. falciparum antibodies was confirmed by inhibition tests: preparations derived from infected blood but not from normal blood inhibited the binding activity of the positive sera, to antigen coated tubes.
用人红细胞(RBC)在体外感染恶性疟原虫,制备了几种类型的抗原(超声处理的感染红细胞以及纯化的、超声处理的裂殖子和裂殖体)。这些抗原以及来自未感染红细胞的对照制剂被用于包被塑料管,随后检测其结合抗恶性疟原虫抗体的能力。通过放射性碘化葡萄球菌蛋白A检测结合情况。近期患病患者或有恶性疟原虫感染史患者的血清呈现强结合,而正常个体的血清仅有低结合活性。阳性血清中的一些抗体针对红细胞,因为它们能与包被有正常红细胞抗原的管子结合,并且可通过用红细胞吸收而去除。通过抑制试验证实了恶性疟原虫抗体的特异性:来自感染血液而非正常血液的制剂抑制阳性血清与抗原包被管的结合活性。